- Home
- INM vs TNON Comparison
INM vs TNON Comparison
Compare INM & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INM | TNON |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | Canada | United States |
| Employees | N/A | 26 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 7.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INM | TNON |
|---|---|---|
| Price | $1.52 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 758.6K | 624.3K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | $65.95 |
| Revenue Next Year | N/A | $50.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $0.18 |
| 52 Week High | $2.50 | $1.74 |
Technical Indicators
Market Signals| Indicator | INM | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | N/A |
| Support Level | $1.09 | N/A |
| Resistance Level | $1.70 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 5.01 | 0.00 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.